XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 106 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $60,692 | -18.2% | 26,974 | -19.7% | 0.00% | – |
| Q1 2024 | $74,229 | +2.4% | 33,588 | +8.9% | 0.00% | – |
| Q4 2023 | $72,495 | +48.1% | 30,849 | +17.2% | 0.00% | – |
| Q3 2023 | $48,940 | -28.7% | 26,312 | +0.5% | 0.00% | – |
| Q2 2023 | $68,618 | +68.3% | 26,190 | +4.7% | 0.00% | – |
| Q1 2023 | $40,768 | -0.6% | 25,011 | -3.9% | 0.00% | – |
| Q3 2022 | $41,000 | +5.1% | 26,029 | +2.4% | 0.00% | – |
| Q2 2022 | $39,000 | +8.3% | 25,428 | +81.8% | 0.00% | – |
| Q1 2022 | $36,000 | -29.4% | 13,983 | -20.4% | 0.00% | – |
| Q4 2021 | $51,000 | – | 17,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,113,348 | $11,505,033 | 58.31% |
| Rosalind Advisors, Inc. | 3,120,170 | $7,020,382 | 5.40% |
| MPM BioImpact LLC | 4,830,526 | $10,868,684 | 1.69% |
| Knott David M Jr | 820,000 | $1,845 | 0.74% |
| CenterBook Partners LP | 1,465,875 | $3,298,219 | 0.20% |
| Redmile Group, LLC | 1,046,587 | $2,354,821 | 0.14% |
| Alpine Global Management, LLC | 300,000 | $675,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 605,663 | $1,363 | 0.10% |
| Invenomic Capital Management LP | 592,078 | $1,332,176 | 0.06% |
| Powell Investment Advisors, LLC | 50,000 | $112,500 | 0.06% |